Geoepidemiology of systemic sclerosis

scientific article

Geoepidemiology of systemic sclerosis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AUTREV.2009.11.003
P698PubMed publication ID19906362

P50authorBrigitte RanqueQ57422100
P2093author name stringLuc Mouthon
P433issue5
P304page(s)A311-8
P577publication date2009-11-10
P1433published inAutoimmunity ReviewsQ15754966
P1476titleGeoepidemiology of systemic sclerosis
P478volume9

Reverse relations

cites work (P2860)
Q38648592An overview of environmental risk factors in systemic sclerosis
Q34024573Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome?
Q33825348Autoimmunity and environment: am I at risk?
Q26998770Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies
Q37841101Celiac disease: a model disease for gene-environment interaction
Q37385700Comparative analysis of educational needs of patients with rheumatic diseases selected based on the Polish version of the Educational Needs Assessment Tool (Pol-ENAT).
Q33857158Compensation for occupational skin diseases
Q37102484Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study
Q38823948Current and future direction in the management of scleroderma.
Q37877594Cutting edge issues in rheumatic fever
Q45959876Cutting-edge issues in organ-specific autoimmunity.
Q37905783Deciphering the genetic background of systemic sclerosis
Q50683587Early identification of vascular damage in patients with systemic sclerosis
Q35674181Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis
Q38071978Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis
Q28390922Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop
Q92003078Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
Q42558630Explosion of autoimmune diseases and the mosaic of old and novel factors
Q34363942Factors associated with development of gastrointestinal problems in patients with scleroderma: a protocol for a systematic review
Q28077405Factors associated with development of gastrointestinal problems in patients with scleroderma: a systematic review
Q93090532Factors associated with quality of life in systemic sclerosis: a cross-sectional study
Q35827986Gender differences in autoimmunity associated with exposure to environmental factors
Q37958780Genetics of systemic sclerosis: an update
Q45932087Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.
Q87866606High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis
Q92263552High risk of gastrointestinal hemorrhage in patients with systemic sclerosis
Q41035757Home parenteral nutrition is beneficial in systemic sclerosis patients with gastrointestinal dysfunction
Q60947878Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis
Q40446240Hyperbaric oxygen therapy for chronic ulcers in systemic sclerosis - case series
Q51835838Immune-Mediated Heart Disease.
Q39332233Incidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil
Q48362710Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population-based study
Q45007419Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis
Q38304255Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future
Q90697873Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016
Q83082263Mechanisms and pathophysiology of autoimmune disease
Q40696023Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.
Q57801056Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China
Q28658168Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells
Q37864261Recommendations for the care of oral involvement in patients with systemic sclerosis
Q90354031Renal pathology and clinical associations in systemic sclerosis: a historical cohort study
Q45245990Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors
Q30458135Role of 2D strain in the early identification of left ventricular dysfunction and in the risk stratification of systemic sclerosis patients
Q42371336Swallowing difficulties with medication intake assessed with a novel self-report questionnaire in patients with systemic sclerosis - a cross-sectional population study
Q38694173Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort
Q84974441The Persistent Challenge of Lupus Nephritis
Q58705720The Role of Oxidative Stress in the Development of Systemic Sclerosis Related Vasculopathy
Q41673061The economic burden and health-related quality of life associated with systemic sclerosis in France
Q43786536The future of autoimmunity
Q37967566The therapeutic potential of epigenetics in autoimmune diseases.
Q92464838Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study
Q37973287Unraveling the genetic component of systemic sclerosis

Search more.